Neurocrine Biosciences, Inc. (NBIX) Tops Q2 EPS by 2c
Tweet Send to a FriendGet Alerts NBIX Hot Sheet
Price: $13.07 +2.91%
Revenue Growth %: -93.8%
Financial Fact:
Deferred gain on real estate: 782K
Today's EPS Names:
ATU, CRWS, CLC, More
Revenue Growth %: -93.8%
Financial Fact:
Deferred gain on real estate: 782K
Today's EPS Names:
ATU, CRWS, CLC, More
Trade NBIX Now!
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q2 EPS of ($0.01), $0.02 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $10.6 million versus the consensus estimate of $11 million.
For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Oppenheimer Starts Neurocrine Bio. (NBIX) at Outperform
- Crown Crafts, Inc. (CRWS) Posts Flat Q4 EPS of 19c
- Korn/Ferry Int'l (KFY) Tops Q4 EPS by 1c, Offers Q1 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
